Meu SciELO
Serviços Personalizados
Journal
Artigo
Indicadores
Citado por SciELO
Acessos
Links relacionados
Citado por Google
Similares em SciELO
Similares em Google
Compartilhar
Actas Urológicas Españolas
versão impressa ISSN 0210-4806
Resumo
JANEIRO PAIS, José Manuel et al. Pulmonary fibrosis and endovesical Mitomycin C. Actas Urol Esp [online]. 2009, vol.33, n.7, pp.822-825. ISSN 0210-4806.
The Mitomycin C is a chemotherapeutic agent used in several types of carcinomas. In the superficial vesical carcinoma comes using since more than a quarter century in the form of endovesical instillations. It is a drug relatively safe, although there have been described adverse effects related to its systemic administration as myelosuppression, anaemia, kidney toxicity and less frequently pulmonary fibrosis. In this article we presented the case of a patient who suffers a respiratory illness compatible with interstitial lung disease that develops a respiratory severe insufficiency finishing with the death, after the administration of endovesical mitomycin C, being this adverse effect exceptional for this route of administration.
Palavras-chave : Mitomycin C; Pulmonary fibrosis.